{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12(1)"],"submitter":["Corren J"],"journal":["ERJ open research"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12926823"],"repository":["biostudies-literature"],"pubmed_title":["FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma"],"pmcid":["PMC12926823"],"pubmed_authors":["Cameron-Christie S","Kell C","Rytelewski M","Belvisi M","Williams A","Georgi B","Lindqvist E","Platt A","Brooks D","Jimenez E","Moate R","Sadiq M","Reid F","Pandya H","Corren J","Muthas D"],"additional_accession":[]},"is_claimable":false,"name":"FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma","description":null,"dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Jan","modification":"2026-07-16T18:33:32.603Z","creation":"2026-07-11T03:08:19.254Z"},"accession":"S-EPMC12926823","cross_references":{}}